References
- 1. Tonkic A, Tonkic M, Lehours P, Megraud F. Epidemiology and diagnosis of Helicobacter pylori infection. Helicobacter 2012; 17:1-8. DOI: 10.1111/j.1523-5378.2012.00975.x10.1111/j.1523-5378.2012.00975.x
- 2. Silva O, Viegas S, de Mello-Sampayo C, Costa MJ, Serrano R, Cabrita J, Gomes ET. Anti-Helicobacter pylori activity of terminalia macroptera root. Fitoterapia 2012; 83(5):872-6. DOI: 10.1016/j.fitote.2012.03.01910.1016/j.fitote.2012.03.019
- 3. Choi JH, Yang YJ, Bang CS, Lee JJ, Baik GH. Current Status of the third-line Helicobacter pylori eradication. Gastroenterol Res Pract. 2018; 2018:6523653. DOI: 10.1155/2018/652365310.1155/2018/6523653
- 4. Chen L, He J, Wang L, Ge Q, Chu H, Chen Y, et al. Efficacies of different proton pump inhibitor-based 14-day bismuth-furazolidone quadruple regimens for the initial eradication of Helicobacter pylori in the southeast coastal region of China:an open-label, randomized clinical trial. Clin Exp Med. 2018 Jun 6. doi:10.1007/s10238-018-0510-9. [Epub ahead of print] DOI: 10.1007/s10238-018-0510-910.1007/s10238-018-0510-9.[Epubaheadofprint]DOI:10.1007/s10238-018-0510-9
- 5. Wu TS, Hu HM, Kuo FC, Kuo CH. Kaohsiung J. Eradication of Helicobacter pylori infection. Med Sci. 2014; 30(4):167-72. DOI: 10.1016/j.kjms.2013.11.00310.1016/j.kjms.2013.11.00324656156
- 6. Hu Y, Zhu Y, Lu NH. Novel and Effective Therapeutic regimens for Helicobacter pylori in an era of increasing antibiotic resistance. Front Cell Infect Microbiol. 2017; 7:168. DOI: 10.3389/fcimb.2017.0016810.3389/fcimb.2017.00168541823728529929
- 7. O’Connor A, Gisbert JP, McNamara D, O’Morain C. Treatment of Helicobacter pylori infection 2010. Helicobacter. 2010; Suppl 1:46-52. DOI: 10.1111/j.1523-5378.2010.00774.x10.1111/j.1523-5378.2010.00774.x21054653
- 8. Talebi Bezmin Abadi A, Yamaoka Y. Helicobacter pylori therapy and clinical perspective. J Glob Antimicrob Resist. 2018; pii:S2213-7165(18)30057-2.
- 9. Amin M, Anwar F, Naz F, Mehmood T, Saari N. Anti-Helicobacter pylori and urease inhibition activities of some traditional medicinal plants. Molecules. 2013; 18(2):2135-49. DOI: 10.3390/molecules1802213510.3390/molecules18022135627035623434867
- 10. Safavi M, Shams-Ardakani M, Foroumadi A. Medicinal plants in the treatment of Helicobacter pylori infections. Pharm Biol. 2015; 53(7):939-60. DOI: 10.3109/13880209.2014.95283710.3109/13880209.2014.95283725430849
- 11. Li K, Ji S, Song W, Kuang Y, Lin Y, Tang S, et al. Glycybridins A-K, bioactive Phenolic compounds from Glycyrrhiza glabra. J Nat Prod. 2017; 80(2):334-46. DOI: 10.1021/acs.jnatprod.6b0078310.1021/acs.jnatprod.6b0078328140583
- 12. Liu W, Sun Z, Qu J, Yang C, Zhang X, Wei X. Correlation between root respiration and the levels of bio-mass and glycyrrhizic acid in Glycyrrhiza uralensis. Exp Ther Med. 2017; 14(3):2323-8. DOI: 10.3892/etm.2017.472310.3892/etm.2017.4723560919928962162
- 13. Kuang Y, Lin Y, Li K, Song W, Ji S, Qiao X, et al. Screening of hepatoprotective compounds from licorice against carbon tetrachloride and acetaminophen induced HepG2 cells injury. Phytomedicine. 2017; 34:59-66. DOI: 10.1016/j.phymed.2017.08.00510.1016/j.phymed.2017.08.00528899510
- 14. Mahmoud AM, Hussein OE, Hozayen WG, Abd El-Twab SM. Methotrexate hepatotoxicity is associated with oxidative stress, and down-regulation of PPARγ and Nrf2:Protective effect of 18β-Glycyrrhetinic acid. Chem Biol Interact. 2017; 270:59-72. DOI: 10.1016/j.cbi.2017.04.00910.1016/j.cbi.2017.04.00928414158
- 15. Yoshida T, Abe K, Ikeda T, Matsushita T, Wake K, Sato T, et al. Inhibitory effect of glycyrrhizin on lipopolysaccharide and d-galactosamine-induced mouse liver injury. Eur J Pharmacol. 2007; 576(1-3):136-42. DOI: 10.1016/j.ejphar.2007.08.01210.1016/j.ejphar.2007.08.01217825282
- 16. Fujii S, Morinaga O, Uto T, Nomura S, Shoyama Y. Development of double eastern blotting for major licorice components, glycyrrhizin and liquiritin for chemical quality control of licorice using anti-glycyrrhizin and anti-liquiritin monoclonal antibodies. J Agric Food Chem. 2016; 64(5):1087-93. DOI: 10.1021/acs.jafc.5b0473210.1021/acs.jafc.5b0473226765784
- 17. Fukazawa K, Seki M, Satoh K, Sugano K. Antimicrobial resistance testing of H. pylori epsilometer test and disk diffusion test. Nihon Rinsho. 1999; 57(1):76-80.
- 18. Owen RJ. Baillieres Clin Gastroenterol. Bacteriology of Helicobacter pylori. 1995; 9(3):415-46.10.1016/0950-3528(95)90041-1
- 19. Marginean OC, Stolnicu S. New diagnostic perspectives related to Helicobacter pylori infection in children. Rev Romana Med Lab, 2009; 15(2):61-8.
- 20. Hirschl AM, Makristathis A. Methods to detect Helicobacter pylori:from culture to molecular biology. Helicobacter. 2007; Suppl 2:6-11. DOI: 10.1111/j.1523-5378.2007.00560.x10.1111/j.1523-5378.2007.00560.x17991170
- 21. O’Mahony R, Al-Khtheeri H, Weerasekera D, Fernando N, Vaira D, Holton J, et al. Bactericidal and anti-adhesive properties of culinary and medicinal plants against Helicobacter pylori. World Journal of Gastroenterology 2005; 11:7499-507. DOI: 10.3748/wjg.v11.i47.749910.3748/wjg.v11.i47.7499472518416437723
- 22. Siddique O, Ovalle A, Siddique AS, Moss SF. Helicobacter pylori Infection:An update for the internist in the age of increasing global antibiotic resistance. Am J Med. 2018; 131(5):473-9. DOI: 10.1016/j.amjmed.2017.12.02410.1016/j.amjmed.2017.12.02429353050
- 23. Johnson KS, Ottemann KM. Colonization, localization, and inflammation:the roles of H. pylori chemotaxis in-vivo. Curr Opin Microbiol. 2018; 41:51-7. DOI: 10.1016/j.mib.2017.11.01910.1016/j.mib.2017.11.019586274929202336
- 24. Ford AC, Gurusamy KS, Delaney B, Forman D, Moayyedi P. Eradication therapy for peptic ulcer disease in Helicobacter pylori-positive people. Cochrane Database Syst Rev. 2016; 4:CD003840. DOI: 10.1002/14651858.CD003840.pub510.1002/14651858.CD003840.pub5716327827092708
- 25. Zhu Y, Zhou X, Wu J, Su J, Zhang G. Risk factors and prevalence of Helicobacter pylori infection in persistent high incidence area of gastric carcinoma in yangzhong city. Gastroenterol Res Pract. 2014; 2014:481365. DOI: 10.1155/2014/48136510.1155/2014/481365391444324550981
- 26. Pereira MI, Medeiros JA. Role of Helicobacter pylori in gastric mucosa-associated lymphoid tissue lymphomas. World J Gastroenterol. 2014; 20(3):684-98. DOI: 10.3748/wjg.v20.i3.68410.3748/wjg.v20.i3.684392147824574742
- 27. Bornschein J, Malfertheiner P. Helicobacter pylori and gastric cancer. Dig Dis. 2014; 32(3):249-64. DOI: 10.1159/00035785810.1159/00035785824732191
- 28. Watari J, Chen N, Amenta PS, Fukui H, Oshima T, Tomita T, et al. Helicobacter pylori associated chronic gastritis, clinical syndromes, precancerous lesions, and pathogenesis of gastric cancer development. World J Gastroenterol. 2014; 20(18):5461-73. DOI: 10.3748/wjg.v20.i18.546110.3748/wjg.v20.i18.5461401706124833876
- 29. Wang F, Meng W, Wang B, Qiao L. Helicobacter pylori-induced gastric inflammation and gastric cancer. Cancer Lett. 2014; 345(2):196-202. DOI: 10.1016/j.canlet.2013.08.01610.1016/j.canlet.2013.08.01623981572
- 30. Nazari S, Rameshrad M, Hosseinzadeh H. Toxicological effects of Glycyrrhiza glabra (Licorice):A Review. Phytother Res. 2017; 31(11):1635-50. DOI: 10.1002/ptr.589310.1002/ptr.589328833680
- 31. Hosseinzadeh H, Nassiri-Asl M. Pharmacological Effects of Glycyrrhiza spp. and Its Bioactive Constituents:Update and Review. Phytother Res. 2015; 29(12):1868-86. DOI: 10.1002/ptr.548710.1002/ptr.548726462981
- 32. Wei M, Ma Y, Liu Y, Zhou Y, Men L, Yue K, et al. Urinary metabolomics study on the anti-inflammation effects of flavonoids obtained from glycyrrhiza. J Chromatogr B Analyt Technol Biomed Life Sci. 2018; 1086:1-10. DOI: 10.1016/j.jchromb.2018.04.00710.1016/j.jchromb.2018.04.00729654981
- 33. Yang N, Patil S, Zhuge J, Wen MC, Bolleddula J, Doddaga S, et al. Glycyrrhiza uralensis flavonoids present in anti-asthma formula, ASHMI™, inhibit memory Th2 responses in vitro and in vivo. Phytother Res. 2013; 27(9):1381-91. DOI: 10.1002/ptr.486210.1002/ptr.4862359375523165939
- 34. Saeedi M, Morteza-Semnani K, Ghoreishi MR. The treatment of atopic dermatitis with licorice gel. J Dermatolog Treat. 2003; 14(3):153-7. DOI: 10.1080/0954663031001436910.1080/0954663031001436914522625
- 35. Fukuchi K, Okudaira N, Adachi K, Odai-Ide R, Watanabe S, Ohno H, et al. Antiviral and antitumor activity of licorice root extracts. In-Vivo. 2016; 30(6):777-85. DOI: 10.21873/invivo.1099410.21873/invivo.1099427815461
- 36. Pu JY, He L, Wu SY, Zhang P, Huang X. Anti-virus research of triterpenoids in licorice]. Bing Du Xue Bao. 2013; 29(6):673-9.
- 37. Fiore C, Eisenhut M, Krausse R, Ragazzi E, Pellati D, Armanini D, et al. Antiviral effects of glycyrrhiza species. Phytother Res. 2008; 22(2):141-8. DOI: 10.1002/ptr.229510.1002/ptr.2295716797917886224
- 38. Sabouri Ghannad M, Mohammadi A, Safiallahy S, Faradmal J, Azizi M, Ahmadvand Z. The effect of aqueous extract of glycyrrhiza glabra on Herpes simplex virus 1. Jundishapur J Microbiol. 2014; 7(7):e11616. DOI: 10.5812/jjm.1161610.5812/jjm.11616421658125368801
- 39. Kalaigandhi V, Poovendran P, Poogunran E. Antimicrobial activity of glycyrrhiza glabra (licorice) against peptic ulcer produced Helicobacter pylori. Int J Curr Pharm Res. 2011; 3(4):93-5.
- 40. Raveendra KR, Jayachandra, Srinivasa V, Sushma KR, Allan JJ, Goudar KS, Shivaprasad HN, et al. An extract of Glycyrrhiza glabra (gutgard) alleviates symptoms of functional dyspepsia:a randomized, double-blind, placebo-controlled study. Evid Based Complement Alternat Med. 2012; 2012:216970. DOI: 10.1155/2012/21697010.1155/2012/216970312399121747893
- 41. Memariani Z, Hajimahmoodi M, Minaee B, Khodagholi F, Yans A, Rahimi R, et al. Protective effect of polyherbal traditional formula consisting of Rosa damascena mill, Glycyrrhiza glabra L. and Nardostachys jatamansi DC., against ethanol-induced gastric ulcer. Iran J Pharm Res. 2017; 16(2):694-707.
- 42. Asha MK, Debraj D, Prashanth D, Edwin JR, Srikanth HS, Muruganantham N, et al. In vitro anti-Helicobacter pylori activity of a flavonoid rich extract of Glycyrrhiza glabra and its probable mechanisms of action. J Ethnopharmacol. 2013; 145(2):581-6. DOI: 10.1016/j.jep.2012.11.03310.1016/j.jep.2012.11.03323220194
- 43. Wang Y, Wang S, Bao Y, Li T, Chang X, Yang G, et al. Multipathway Integrated adjustment mechanism of glycyrrhiza triterpenes curing gastric ulcer in rats. Pharmacogn Mag. 2017; 13(50):209-215. DOI: 10.4103/0973-1296.20455010.4103/0973-1296.204550542141428539709